Eiji Kudo

2.2k total citations
59 papers, 1.6k citations indexed

About

Eiji Kudo is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Eiji Kudo has authored 59 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 15 papers in Pulmonary and Respiratory Medicine and 14 papers in Molecular Biology. Recurrent topics in Eiji Kudo's work include Sarcoma Diagnosis and Treatment (10 papers), Cell Adhesion Molecules Research (6 papers) and Pituitary Gland Disorders and Treatments (5 papers). Eiji Kudo is often cited by papers focused on Sarcoma Diagnosis and Treatment (10 papers), Cell Adhesion Molecules Research (6 papers) and Pituitary Gland Disorders and Treatments (5 papers). Eiji Kudo collaborates with scholars based in Japan, Canada and Germany. Eiji Kudo's co-authors include Toshiaki Sano, Zhi Rong Qian, Katsuhiko Yoshimoto, Takanori Hirose, Kazuo Hizawa, Shozo Yamada, Tadashi Hasegawa, Mitsuo Itakura, Md. Mustafizur Rahman and Masahiko Nakasono and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and Kidney International.

In The Last Decade

Eiji Kudo

57 papers receiving 1.6k citations

Peers

Eiji Kudo
T Sano Japan
Sanjay Logani United States
Rogers C. Griffith United States
Eugene Friedman United States
V A Memoli United States
Annemieke van Zante United States
Eiji Kudo
Citations per year, relative to Eiji Kudo Eiji Kudo (= 1×) peers Ingrid Laurendeau

Countries citing papers authored by Eiji Kudo

Since Specialization
Citations

This map shows the geographic impact of Eiji Kudo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eiji Kudo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eiji Kudo more than expected).

Fields of papers citing papers by Eiji Kudo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eiji Kudo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eiji Kudo. The network helps show where Eiji Kudo may publish in the future.

Co-authorship network of co-authors of Eiji Kudo

This figure shows the co-authorship network connecting the top 25 collaborators of Eiji Kudo. A scholar is included among the top collaborators of Eiji Kudo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eiji Kudo. Eiji Kudo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kudo, Eiji, et al.. (2023). Acute hemorrhagic cholecystitis related to diffuse neurofibroma of gallbladder in a patient with neurofibromatosis type 1. SHILAP Revista de lepidopterología. 9(1). 62–62.
2.
Tonogai, Ichiro, Mitsuhiko Takahashi, Hiroaki Manabe, et al.. (2013). A Massive Chondroblastoma in the Proximal Humerus Simulating Malignant Bone Tumors. SHILAP Revista de lepidopterología. 2013(1). 673576–673576. 2 indexed citations
3.
Qian, Zhi Rong, Masahiko Nakasono, Toshihito Tanahashi, et al.. (2010). High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer. British Journal of Cancer. 102(5). 908–915. 210 indexed citations
4.
Qian, Zhi Rong, L. Sylvia, Haruhiko Siomi, et al.. (2009). Overexpression of HMGA2 relates to reduction of the let-7 and its relationship to clinicopathological features in pituitary adenomas. Modern Pathology. 22(3). 431–441. 97 indexed citations
5.
Wang, Elaine Lu, Zhi Rong Qian, Shozo Yamada, et al.. (2009). Clinicopathological Characterization of TSH-Producing Adenomas: Special Reference to TSH-immunoreactive but Clinically Non-functioning Adenomas. Endocrine Pathology. 20(4). 209–220. 43 indexed citations
6.
Abe, Akiko, Hiroyuki Furumoto, Kaya Yoshida, et al.. (2008). A case of ovarian endometrioid adenocarcinoma with a yolk sac tumor component. International Journal of Gynecological Cancer. 18(1). 168–172. 3 indexed citations
7.
Yuan, Yunfeng, Zhi Rong Qian, Toshiaki Sano, et al.. (2008). Reduction of GSTP1 expression by DNA methylation correlates with clinicopathological features in pituitary adenomas. Modern Pathology. 21(7). 856–865. 24 indexed citations
8.
Sano, Toshiaki, Ken-ichi Ohyama, Eiji Kudo, et al.. (2008). Clinicopathological Features of Growth Hormone-producing Pituitary Adenomas: Difference among Various Types Defined by Cytokeratin Distribution Pattern Including a Transitional Form. Endocrine Pathology. 19(2). 82–91. 140 indexed citations
9.
Kimura, Tetsuo, Naoki Muguruma, Susumu Ito, et al.. (2007). Infrared fluorescence endoscopy for the diagnosis of superficial gastric tumors. Gastrointestinal Endoscopy. 66(1). 37–43. 36 indexed citations
10.
Moritani, Maki, Kyoko Nomura, Toshihito Tanahashi, et al.. (2007). Genetic association of single nucleotide polymorphisms in endonuclease G-like 1 gene with type 2 diabetes in a Japanese population. Diabetologia. 50(6). 1218–1227. 10 indexed citations
11.
Kunika, Kiyoshi, Toshihito Tanahashi, Eiji Kudo, et al.. (2006). Effect of +36T > C in intron 1 on the glutamine: fructose-6-phosphate amidotransferase 1 gene and its contribution to type 2 diabetes in different populations. Journal of Human Genetics. 51(12). 1100–1109. 2 indexed citations
13.
Kudo, Eiji, et al.. (2000). A Case of Leber's Stellate Neuroretinitis Presumably Caused by Bartonella henselae Infection. 51(8). 793–796. 1 indexed citations
14.
Iwahana, Hiroyuki, Jun Oka, Noriko Mizusawa, et al.. (1993). Molecular Cloning of Human Amidophosphoribosyltransferase. Biochemical and Biophysical Research Communications. 190(1). 192–200. 19 indexed citations
15.
Hirose, Takanori, Tadashi Hasegawa, Eiji Kudo, et al.. (1992). Malignant peripheral nerve sheath tumors: An immunohistochemical study in relation to ultrastructural features. Human Pathology. 23(8). 865–870. 61 indexed citations
16.
Hasegawa, Tadashi, Takanori Hirose, Eiji Kudo, et al.. (1991). Immunophenotypic heterogeneity in osteosarcomas. Human Pathology. 22(6). 583–590. 70 indexed citations
17.
Hasegawa, Tadashi, Takanori Hirose, Eiji Kudo, et al.. (1991). Atypical Primitive Neuroectodermal Tumors Comparative Light and Electron Microscopic and Immunohistochemical Studies on Peripheral Neuroepitheliomas and Ewing's Sarcomas. Acta Pathologica Japonica. 41(6). 444–454. 12 indexed citations
18.
Kudo, Eiji, et al.. (1991). Undifferentiated Carcinoma of the Vulva Mimicking Epithelioid Sarcoma. The American Journal of Surgical Pathology. 15(10). 990–1001. 14 indexed citations
19.
Sumitomo, Masayuki, et al.. (1989). Epithelial Differentiation in Synovial Sarcoma Correlation with Histology and Immunophenotypic Expression. Acta Pathologica Japonica. 39(6). 381–387. 8 indexed citations
20.
Hasegawa, Tadashi, Takanori Hirose, Eiji Kudo, & Kazuo Hizawa. (1989). Clear Cell Sarcoma. An Immunohistochemical and Ultrastructural Study. Pathology International. 39(5). 321–327. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026